xl-220

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug Namexl-220
Drug Alias NameCD20 Fab Imaging Agent (XL-Protein)
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody fragment
Mechanisms of ActionB-lymphocyte antigen CD20 modulators
TargetsB-lymphocyte antigen CD20
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryGermany
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesXL-protein GmbH
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesXL-protein GmbH
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A